BioSpace News Archive

Drug Development

Merck, Ridgeback Embark on Phase III with COVID-19 Therapeutic

The study of Molnupiravir will assess 1,300 adult participants 18 and over who cohabitate with someone who has tested positive for the coronavirus and is symptomatic.

September 1, 2021
·
2 min read
·
Heather McKenzie
FDA

Mesoblast’s COVID-19 Respiratory Therapy Hits Another Snag on Route to Potential EUA

Mesoblast shares dropped on the last day of August 2021 after it was told that its candidate COVID-19 treatment needs to undergo another trial to be green-lit for emergency approval by the FDA.

September 1, 2021
·
2 min read
·
Vanessa Doctor, RN
Pharm Country

Leading Medical Journal Validates Potential of Zentalis-discovered Cancer Therapy

ZN-c3 is a WEE1 inhibitor that could be used as monotherapy for uterine serous carcinoma and solid tumors, as well as combination therapy for ovarian cancer, alongside chemotherapy.

September 1, 2021
·
2 min read
·
Vanessa Doctor, RN
Genetown

Fractyl Announces Tenth Trial Site Opened in REVITA-T2Di Study of Revita® DMR for Type 2 Diabetes

Fractyl Health, a life sciences company dedicated to developing novel therapeutic interventions aimed at reversing the metabolic disease epidemic, today announced the activation of the tenth clinical site in the company’s pivotal REVITA-T2Di trial taking place across the U.S. and Europe.

September 1, 2021
·
4 min read
Genetown

AVROBIO to Participate at Four Upcoming Investor Conferences

AVROBIO, Inc. today announced that members of its senior management team are scheduled to participate in four upcoming virtual investor conferences.

September 1, 2021
·
5 min read
Genetown

Keystone Dental Announces Completion of $25 Million Financing to Accelerate Growth of Dental Implant and Digital Dentistry Portfolio

Keystone Dental Inc., the largest independent dental implant company operating in North America, announced a $25 million financing.

September 1, 2021
·
2 min read
Lone Star Bio

Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System

Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System

September 1, 2021
·
5 min read
Business

ProMIS Neurosciences appoints accomplished biotechnology executive, Josh Mandel-Brehm, to its Board of Directors

ProMIS Neurosciences, Inc. today announced the appointment of Josh Mandel-Brehm to its Board of Directors with immediate effect.

September 1, 2021
·
4 min read
Biotech Bay

Invitae to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Invitae Corporation today announced that members of its management team will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021 , at 12:30pm Eastern Time .

September 1, 2021
·
1 min read
Biotech Beach

Arrowhead Pharmaceuticals to Participate in Upcoming September 2021 Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: Citi’s 16th Annual BioPharma Virtual Conference – September 8-10, 2021

September 1, 2021
·
4 min read